Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change

Jul 2020| TBR1061A| TBRC (Publisher)

Report Highlights

Including:

1) By Route of Administration: Oral; Intravenous
2) By Dosage Form: Tablets; Frozen Solution; Lypholized Solution
3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Others

Covering: Gilead Sciences, Inc.; Bright Gene; Hainan Haiyao; Kelun Pharma; Hunan Warrant Pharmaceutical

Remdesivir Global Market Report 2020-30: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global remdesivir market.

This report focuses on remdesivir market which is experiencing strong growth. The report gives a guide to the remdesivir market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the remdesivir? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Remdesivir market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider remdesivir market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The remdesivir market section of the report gives context. It compares the remdesivir market with other segments of the remdesivir market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, remdesivir indicators comparison.

Scope

Markets Covered: 1) By Route of Administration: Oral; Intravenous
2) By Dosage Form: Tablets; Frozen Solution; Lypholized Solution
3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Others

Companies Mentioned: Gilead Sciences, Inc.; Bright Gene; Hainan Haiyao; Kelun Pharma; Hunan Warrant Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2 : Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3 : Global Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4 : Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5 : Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6 : Global Remdesivir Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7 : Global Remdesivir Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8 : Asia-Pacific, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9 : Asia-Pacific, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10 : China, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11 : China, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12 : India, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13 : India, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14 : Japan, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15 : Japan, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16 : Australia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17 : Australia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18 : Indonesia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19 : Indonesia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20 : South Korea, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21 : South Korea, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22 : Western Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23 : Western Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24 : UK, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25 : UK, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26 : Germany, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27 : Germany, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28 : France, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29 : France, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30 : Eastern Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31 : Eastern Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32 : Russia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33 : Russia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34 : North America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35 : North America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36 : USA, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37 : USA, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38 : South America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39 : South America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40 : Brazil, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41 : Brazil, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42 : Middle East, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43 : Middle East, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44 : Africa, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45 : Africa, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 46 : Gilead Sciences, Inc. Financial Performance
  • Table 47 : Bright Gene Financial Performance
  • Table 48 : Hainan Haiyao Financial Performance
  • Table 49 : Kelun Pharma Financial Performance
  • Table 50 : Hunan Warrant Pharmaceutical Financial Performance
  • Figure 1 : Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3 : Global Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4 : Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5 : Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6 : Global Remdesivir Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7 : Global Remdesivir Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8 : Asia-Pacific, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9 : Asia-Pacific, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10 : China, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11 : China, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12 : India, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13 : India, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14 : Japan, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15 : Japan, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16 : Australia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17 : Australia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18 : Indonesia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19 : Indonesia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20 : South Korea, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21 : South Korea, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22 : Western Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23 : Western Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24 : UK, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25 : UK, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26 : Germany, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27 : Germany, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28 : France, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29 : France, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30 : Eastern Europe, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31 : Eastern Europe, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32 : Russia, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33 : Russia, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34 : North America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35 : North America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36 : USA, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37 : USA, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38 : South America, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39 : South America, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40 : Brazil, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41 : Brazil, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42 : Middle East, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43 : Middle East, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44 : Africa, Remdesivir Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45 : Africa, Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 46 : Gilead Sciences, Inc. Financial Performance
  • Figure 47 : Bright Gene Financial Performance
  • Figure 48 : Hainan Haiyao Financial Performance
  • Figure 49 : Kelun Pharma Financial Performance
  • Figure 50 : Hunan Warrant Pharmaceutical Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report